Nakho Chang

1.3k total citations · 1 hit paper
6 papers, 846 citations indexed

About

Nakho Chang is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Nakho Chang has authored 6 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Cancer Research. Recurrent topics in Nakho Chang's work include Glioma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and MicroRNA in disease regulation (2 papers). Nakho Chang is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and MicroRNA in disease regulation (2 papers). Nakho Chang collaborates with scholars based in South Korea, United States and Ethiopia. Nakho Chang's co-authors include Do‐Hyun Nam, Young Taek Oh, Kyeung Min Joo, Eun Hee Kim, Jeongwu Lee, Misuk Kim, Cheolju Lee, Dong‐Hun Woo, Jeremy N. Rich and Hong Kim and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Cell and Oncotarget.

In The Last Decade

Nakho Chang

6 papers receiving 844 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells

2013 626 citations Eun Hee Kim, Misuk Kim et al. Cancer Cell profile →

Peers

Nakho Chang

MB

CR

ONCOL

GENET

IMMUN

Lauretta Levati Italy

Jun-Kyum Kim South Korea

Deanna Tiek United States

Dorthe Aasland Germany

Dorine Bellanger France

Seok Won Ham South Korea

Julie Dwyer France

Lisa Nonnenmacher Germany

Alba Gonzàlez-Juncà United States

Raquel Parı́s Spain

Lauretta Levati Italy

Nakho Chang

699 ×1.1

MB

292 ×1.2

CR

279 ×1.1

ONCOL

75 ×0.6

GENET

134 ×1.1

IMMUN

Citations per year, relative to Nakho Chang Nakho Chang (= 1×) peers Lauretta Levati

Countries citing papers authored by Nakho Chang

Since Specialization

Citations

This map shows the geographic impact of Nakho Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nakho Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nakho Chang more than expected).

Fields of papers citing papers by Nakho Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nakho Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nakho Chang. The network helps show where Nakho Chang may publish in the future.

Co-authorship network of co-authors of Nakho Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Nakho Chang. A scholar is included among the top collaborators of Nakho Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nakho Chang. Nakho Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jeon, Hye-Min, Yong Jae Shin, Jaehyun Lee, et al.. (2023). The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling. JCI Insight. 8(21). 8 indexed citations

2.

Shin, Yong Jae, K. Jason, Yeri Lee, et al.. (2019). PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma. The Journal of Experimental Medicine. 216(5). 1120–1134. 33 indexed citations

3.

Chang, Nakho, Sun Hee Ahn, Doo‐Sik Kong, Hye Won Lee, & Do‐Hyun Nam. (2017). The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Molecular and Cellular Endocrinology. 451. 53–65. 79 indexed citations

4.

Chang, Nakho, Hye Won Lee, Joung Eun Lim, et al.. (2016). Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion. Oncotarget. 7(32). 51626–51639. 9 indexed citations

5.

Lee, Jin‐Ku, Nakho Chang, Yeup Yoon, et al.. (2015). USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance. Neuro-Oncology. 18(1). 37–47. 91 indexed citations

6.

Kim, Eun Hee, Misuk Kim, Dong‐Hun Woo, et al.. (2013). Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells. Cancer Cell. 23(6). 839–852. 626 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact